Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2015 Mar 26:15:183.
doi: 10.1186/s12885-015-1215-z.

Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas

Affiliations
Case Reports

Breast cancer and neurofibromatosis type 1: a diagnostic challenge in patients with a high number of neurofibromas

André Vallejo Da Silva et al. BMC Cancer. .

Abstract

Background: Neurofibromatosis 1 is one of the most common genetic diseases in humans, presenting with multiple neurofibromas and an increased risk of various benign and malignant tumors, including breast cancer.

Case presentation: In this paper we report a case of a woman with neurofibromatosis 1 and the challenge associated with detecting an advanced breast cancer because of numerous skin neurofibromas, which were responsible for a substantial delay in cancer diagnosis. Literature concerning the association of neurofibromatosis 1 and breast cancer is reviewed and discussed.

Conclusions: Best practice guidelines for breast cancer detection are not sufficient for the screening of neurofibromatosis 1 carriers. A more intensive clinical and imaging approach should be used if the same early detection rate as in non-neurofibromatosis 1 women is to be achieved.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Clinical aspect of the patient before mastectomy. Photograph showing the high number of skin neurofibromas. Note that the left breast is enlarged.
Figure 2
Figure 2
Radiological aspect of the digital mammogram before surgery. Mammogram illustrating the difficulty in identifying the tumor mass due to the high number of skin neurofibromas.

Similar articles

Cited by

References

    1. Cunha KSG, Geller M. Advances in Neurofibromatosis Research. New York: Nova Science Publishers Inc; 2011.
    1. Rodrigues LOC, Batista PB, Goloni-Bertollo EM, de Souza-Costa D, Eliam L, Eliam M, et al. Neurofibromatoses: part 1 - diagnosis and differential diagnosis. Arq Neuropsiquiatr. 2014;72(3):241–50. doi: 10.1590/0004-282X20130241. - DOI - PubMed
    1. Cunha KS, Caruso AC, de Faria PAS, da Silva LE, Pires ARC, Geller M. Malignant peripheral nerve sheath tumors: clinicopathological aspects, expression of p53 and survival. Clin São Paulo Braz. 2012;67(8):963–8. doi: 10.6061/clinics/2012(08)18. - DOI - PMC - PubMed
    1. Alamsamimi M, Mirkheshti N, Mohajery M-R, Abdollahi M. Bilateral invasive ductal carcinoma in a woman with neurofibromatosis type 1. Arch Iran Med. 2009;12(4):412–4. - PubMed
    1. Walker L, Thompson D, Easton D, Ponder B, Ponder M, Frayling I. A prospective study of neurofibromatosis type 1 cancer incidence in the UK. Br J Cancer. 2006;95(2):233–8. doi: 10.1038/sj.bjc.6603227. - DOI - PMC - PubMed

Publication types

MeSH terms